Michael Shine
Chief Executive Officer of Issuer at NK-One Therapeutics.
- Wayne, PA
- Form D signer
- NK-One Therapeutics
Raised on NK-One Therapeutics filings
$290K
of $310K offered across 1 Form D filing
- Form D filings
- 1
- Teammates
- 1
- Last filing
- Apr 27, 2026
Company
Spinal injection therapy for intractable cancer pain
- Investors
- 7
- Founded
- 2026
- Still open
- $20K
NK-One Therapeutics filings
| Filed | Security | Sold of offered | Filing |
|---|---|---|---|
| Apr 27, 2026 | Security to be acquired | $290K/ $310K | Form D |
- Security to be acquiredFiled Apr 27, 2026Form D$290K/ $310K
